Loading...
Loading...
Analysts at Chardan Capital initiated coverage on
Signal Genetics IncSGNL with a Buy rating.
The target price for Signal Genetics is set to $2.50.
Signal Genetics shares have dropped 80.76 percent over the past 52 weeks, while the S&P 500 index has surged 8.87 percent in the same period.
Signal Genetics' shares rose 1.32 percent to close at $1.53 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in